Compounds and methods for treatment of chemotherapy-induced anemia

a technology of chemotherapy-induced anemia and compounds, which is applied in the direction of phosphorous compound active ingredients, drug compositions, metabolic disorders, etc., can solve the problems of subject being considered refractory, and achieve the effect of inhibiting hif hydroxylase activity and reducing weight loss

Active Publication Date: 2007-12-20
FIBROGEN INC
View PDF1 Cites 53 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0013]The invention provides in one embodiment a method for reducing weight loss in a subject who is undergoing, has undergone, or is expected to undergo chemotherapy, the method comprising administering to the subject an effective amount of an agent that inhibits HIF hydroxylase activity.

Problems solved by technology

If a subject does not display such a response within the required period of time, that subject is deemed refractory to treatment with recombinant human EPO.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compounds and methods for treatment of chemotherapy-induced anemia
  • Compounds and methods for treatment of chemotherapy-induced anemia
  • Compounds and methods for treatment of chemotherapy-induced anemia

Examples

Experimental program
Comparison scheme
Effect test

example 1

Compounds and Methods of the Invention Are Effective at Treating Chemotherapy-Induced Anemia

[0313]The following study was performed to examine the effect of compounds and methods of the present invention on treatment of chemotherapy-induced anemia. Fifteen Sprague Dawley male rats (280-300 g) were obtained from Charles River Laboratories. On day 0, rats were treated by intraperitoneal (i.p.) injection with a single dose of saline (control; n=3) at 8 ml / kg, or Cisplatin (CP; Bedford Laboratories, Bedford Ohio) at either 7 mg / kg (7 ml / kg; n=6) or 10 mg / kg (10 ml / kg; n=6). Blood samples (0.2 ml) were collected on days 5, 9, and 16 as follows. Animals were anesthetized with isoflurane and 0.2 ml of blood was collected from the tail vein into a MICROTAINER EDTA-2K tube (Becton-Dickinson). Blood samples were processed for hematocrit as described above to determine the degree of anemia produced in each animal.

[0314]Beginning on day 19 of the study, one half of each cisplatin-treated group ...

example 2

Compounds and Methods of the Invention Are Effective at Treating Chemotherapy-Induced Anemia

[0318]To examine the effect of methods and compounds of the present invention on treatment of chemotherapy-induced anemia, the following study was performed. The human H-460 lung cancer cell line used was obtained from the National Cancer Institute. (Brower et al., (1986) Cancer Res 46:798-806.) Animals were maintained in a HEPA-filtered environment during the experimental period. Cages, food, and bedding were autoclaved. Animal diets were obtained from Harlan Teklad (Madison, Wis.). Hydrochloric acid, 0.15% (v / v), was added to the drinking water.

[0319]Compounds of the invention were pre-formulated in an aqueous vehicle consisting of 0.1% (w / w) Polysorbate 80 (JT Baker) and 0.5% (w / w) high viscosity carboxymethyl cellulose sodium (Spectrum) to achieve a final 10 ml / kg dosing (oral gavage).

[0320]A stock tumor was established by subcutaneously injecting a cell suspension into nude mice. The res...

example 3

Compounds and Methods of the Invention Limit Weight Loss Associated with Chemotherapy

[0328]To examine the effects of compounds and methods of the present invention on weight loss associated with chemotherapeutic agents, the following study was performed. This experiment was carried out essentially as described above in Example 2. The human H-460 lung cancer cell line used was obtained from the National Cancer Institute. (Brower et al., (1986) Cancer Res 46:798-806.) Animals were maintained in a HEPA-filtered environment during the experimental period. Cages, food, and bedding were autoclaved. Animal diets were obtained from Harlan Teklad (Madison, Wis.). Hydrochloric acid, 0.15% (v / v), was added to the drinking water.

[0329]Compounds of the invention were pre-formulated in an aqueous vehicle consisting of 0.1% (w / w) Polysorbate 80 (JT Baker) and 0.5% (w / w) high viscosity carboxymethyl cellulose sodium (Spectrum) to achieve a final 10 ml / kg dosing (oral gavage).

[0330]A stock tumor was...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
concentrationaaaaaaaaaa
weight lossaaaaaaaaaa
Login to view more

Abstract

The invention relates to methods and compounds for treating chemotherapy-induced anemia. In particular, methods for treating chemotherapy-induced anemia in subjects refractory to treatment with recombinant human erythropoietin are encompassed herein.

Description

FIELD OF THE INVENTION[0001]The invention relates to methods and compounds for treating chemotherapy-induced anemia. In particular, methods for treating chemotherapy-induced anemia in subjects refractory to treatment with recombinant human erythropoietin are encompassed herein.BACKGROUND OF THE INVENTION[0002]Chemotherapeutic agents are known suppressors of red cell production by the bone marrow, and over 60% of patients treated with chemotherapy develop anemia resulting in decreased functional capacity and quality of life. In contrast to other common side effects experienced by patients undergoing treatment for cancer, chemotherapy-induced anemia (CIA) is often a “silent” side effect with insidious symptoms. CIA can be one of the most common underlying etiologies of the fatigue in cancer patients. Most chemotherapeutic agents also cause stomach upset, resulting in nausea and vomiting, which can severely reduce appetite and produce substantial weight loss in the patient. CIA is also...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K39/395A61K38/46A61K31/7072A61K31/704A61K31/66A61K31/56A61K31/525A61K31/522A61K31/454A61K31/337
CPCA61K45/06A61K31/472A61P3/00A61P35/00A61P43/00A61P7/06
Inventor SEELEY, TODD W.LIU, DAVID Y.KLAUS, STEPHEN J.
Owner FIBROGEN INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap